| Serial Number | 79316047 |
| Word Mark | RENLITE |
| Filing Date | Wednesday, February 24, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 3, 2022 |
| Registration Number | 6714947 |
| Registration Date | Tuesday, May 3, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 15, 2022 |
| Goods and Services | Vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; medicines for human purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposes, namely, antibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases |
| Pseudo Mark | REN LITE; REN LIGHT |
| Goods and Services | Live trees; live plants; live animals; poultry, live; pigs, live; hamsters, live; live laboratory animals; plant seeds; fodder; litter for animals |
| Goods and Services | Evaluation of pharmaceutical products; technological research, namely, pharmaceutical research; conducting early evaluation in the field of new pharmaceuticals; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 27, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt. |
| US Class Codes | 001, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 27, 2021 |
| Primary Code | 031 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 27, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Saturday, March 25, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, October 3, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Sunday, September 4, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
| Sunday, September 4, 2022 | GENERIC MADRID TRANSACTION CREATED |
| Wednesday, August 3, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, May 3, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 15, 2022 | PUBLISHED FOR OPPOSITION |
| Monday, February 14, 2022 | NOTIFICATION PROCESSED BY IB |
| Wednesday, January 26, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 26, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 26, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, January 8, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 7, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 7, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, January 7, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, November 5, 2021 | REFUSAL PROCESSED BY IB |
| Friday, October 8, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, October 8, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, September 24, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, September 23, 2021 | NON-FINAL ACTION WRITTEN |
| Sunday, September 19, 2021 | ASSIGNED TO EXAMINER |
| Saturday, July 31, 2021 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, July 27, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 22, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |